How are you feeling today? Keep up to date on news and stories related to health care here!
Dr. Reddy’s announces the launch of Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection in the U.S. Market, HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”)
How can I tell the difference between the flu and COVID-19? — FOX News
Johnson & Johnson plans to enroll 60,000 participants in its Phase 3 trials. Dr. Anthony Fauci and other top U.S. health officials are scheduled to testify before a Senate panel today. — NYT: Top Stories
Immetas Therapeutics Announces Series A Financing to Advance Research on Inflammation Pathways in Aging and Develop Therapeutics for Cancer and Inflammatory Disease, EAST HANOVER, N.J.–(BUSINESS WIRE)–Immetas Therapeutics today announced it has raised a Series A financing of $11 million to advance research
Experts weigh in on what the future may hold amid the pandemic. — ABC News: Top Stories
The novel coronavirus was apparently no match for a 102-year-old woman in New Hampshire. FOX News: Madeline Farber
Clinical trials have not included children, so vaccines for them may not arrive until the next school year, while adults may get theirs by summer. — NYT: Top Stories
Pathline Labs Doubles Testing Capacity for COVID-19, Adds Major Clients Throughout U.S., Testing through Pathline Labs is now available nationwide RAMSEY, N.J.–(BUSINESS WIRE)–Pathline Labs, a leading provider of sub-specialized anatomic pathology, has expanded its COVID-19 testing capabilities across the country while maintaining
The staggering toll of the pandemic comes as at least 73 countries are seeing surges in newly detected cases. — NYT: Top Stories